21 – 30 of 36
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Efficacy and safety of inhaled α1-antitrypsin in patients with severe α1-antitrypsin deficiency and frequent exacerbations of COPD
(
- Contribution to journal › Article
- 2018
-
Mark
Missed opportunity? Worsening breathlessness as a harbinger of death : A cohort study
(
- Contribution to journal › Article
-
Mark
Impact of age and comorbidity on risk stratification in idiopathic pulmonary arterial hypertension
(
- Contribution to journal › Article
- 2017
-
Mark
Survival in individuals with severe alpha 1-antitrypsin deficiency (PiZZ) in comparison to a general population with known smoking habits
(
- Contribution to journal › Article
-
Mark
LSC - 2017 - Hippo-YAP/TAZ signaling is deranged in IPF
(
- Contribution to journal › Published meeting abstract
-
Mark
European Respiratory Society statement : Diagnosis and treatment of pulmonary disease in α1-antitrypsin deficiency
(
- Contribution to journal › Article
-
Mark
Risk of pulmonary embolism and deep venous thrombosis in patients with asthma : A nationwide case-control study from Sweden
(
- Contribution to journal › Article
-
Mark
Incident opioid drug use and adverse respiratory outcomes among older adults with COPD
(
- Contribution to journal › Letter
-
Mark
ERS technical standard on bronchial challenge testing : General considerations and performance of methacholine challenge tests
(
- Contribution to journal › Article
- 2016
-
Mark
Incidence and familial risk of pleural mesothelioma in Sweden : A national cohort study
(
- Contribution to journal › Article